U.S. Wireless Telecom Stock News

NasdaqGM:AMAL
NasdaqGM:AMALBanks

What Amalgamated Financial (AMAL)'s Strong Q2 Results And New Buyback Mean For Shareholders

In July 2026, Amalgamated Financial Corp. reported second-quarter 2026 results showing higher net interest income of US$86.06 million and net income of US$34.77 million year over year, while also authorizing a new US$40 million share repurchase program and affirming a quarterly dividend of US$0.17 per share. The combination of stronger profitability and a fresh buyback authorization highlights management’s confidence in the bank’s capital position and ongoing earnings power, alongside a...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure (NVCR) Is Up 10.9% After Raising 2026 Revenue Outlook and Securing New CE Mark Approval – Has The Bull Case Changed?

NovoCure recently reported its strongest-ever second quarter, with net revenue rising to US$183.58 million, a smaller net loss of US$15.66 million, and an upgraded 2026 net revenue outlook to US$710 million–US$725 million. The company also secured a CE Mark for its Optune Pax device in locally advanced pancreatic cancer and is anticipating FDA premarket approval for TTFields in brain metastases from non-small cell lung cancer, underscoring how expanding indications could reshape its...
NYSE:THC
NYSE:THCHealthcare

Tenet Healthcare (THC) Raised Full Year Guidance, Does It Look Fairly Valued?

Tenet Healthcare (THC) is back on investors' radar after second quarter 2026 earnings and new full year guidance pointed to stronger profitability, higher revenue expectations and a larger share repurchase program. See our latest analysis for Tenet Healthcare. The latest earnings and guidance reset have clearly shifted sentiment, with Tenet Healthcare’s share price up 17.17% on the day and posting a 25.69% 3 month share price return. The 1 year total shareholder return of 52.40% and 3 year...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Stock Looks Rich Despite Near Fair Value

Edwards Lifesciences stock sits in an interesting spot for investors right now, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the current price is roughly in line with fair value, while the broader valuation checks and recent 5 year share price record do not point to a clear bargain. Over the past 5 years, Edwards Lifesciences shares have declined 26.4%, which puts more focus on whether today’s price now fairly reflects the company’s prospects. Recent optimism...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Does Stoke Therapeutics’ New Genetic Medicine CSO Hire Reframe Its R&D Ambitions for STOK?

Earlier this month, Stoke Therapeutics appointed Thomas McCauley, Ph.D., as Chief Scientific Officer, adding more than 25 years of R&D and rare disease drug development leadership to its senior team. His background in advancing genetic and RNA-based medicines, including experience with mRNA technologies and antisense platforms, could be particularly relevant to Stoke’s antisense oligonucleotide programs targeting severe genetic diseases. Next, we’ll examine how bringing in a Chief Scientific...
NYSE:C
NYSE:CBanks

Citigroup (C) Stock Still Looks Reasonable Even After A 208% Run

Citigroup stock has logged a very large 207.6% return over the past three years, yet current checks suggest it still trades at a discount, with both the Excess Returns intrinsic value estimate and earnings multiples pointing to an undervalued profile rather than a stretched one. Over the past three years, Citigroup has delivered a 207.6% return, which puts the current share price in focus against what the underlying value signals suggest. Recent progress on Citi's multi year transformation,...
NYSE:BYD
NYSE:BYDHospitality

Is Boyd Gaming’s Higher Online Guidance Offsetting Softer Q2 Profit Trends For BYD?

Boyd Gaming reported past second-quarter 2026 results showing sales of US$733.7 million and revenue of US$1.03 billion, with net income easing to US$131.23 million and diluted EPS from continuing operations at US$1.75. Despite flat overall revenue and lower net income, Boyd Gaming highlighted growth in its Midwest and South operations, continued share repurchases and dividends above US$170 million, and raised guidance for its Online and Managed businesses. Now we’ll examine how Boyd Gaming’s...
NYSE:ICE
NYSE:ICECapital Markets

Intercontinental Exchange (ICE) Draws Fresh Interest After Mortgage Data Update As Valuation Debate Builds

Intercontinental Exchange (ICE) has attracted fresh attention after releasing its June 2026 First Look on mortgage delinquency and foreclosure trends, highlighting sharply lower new FHA defaults and continued low early stage delinquencies. See our latest analysis for Intercontinental Exchange. Intercontinental Exchange shares have picked up momentum recently, with a 30 day share price return of 17.71% and a 7 day gain of 4.40%. This comes even though the year to date share price return is...
NasdaqGS:AEVA
NasdaqGS:AEVAElectronic

Aeva Technologies (AEVA) Stock Looks Overvalued On Sales But Strong On Returns

Aeva Technologies stock has delivered a very large 3 year gain, yet the current checks lean toward the shares trading at a premium rather than offering clear value today. Aeva Technologies is up 143.4% over 3 years, a result that puts long term holders in a strong position even though the share price has recently come under pressure. Future growth expectations for its sensing technology can support investor enthusiasm, but the path to consistent cash generation and funding its development...
NasdaqGS:ENTG
NasdaqGS:ENTGSemiconductor

Entegris (ENTG) Stock May Look Fully Priced On Earnings Expectations

Entegris stock has gained 44.2% year to date, yet the valuation checks lean expensive, raising the question of how much of the story is already reflected in the current price. Year to date, Entegris is up 44.2%, which means recent buyers are paying a substantially higher price than at the start of the year. Expectations for continued growth in Entegris' semiconductor materials business can support a premium, but any disappointment in execution or industry demand may weigh heavily on what...
NYSE:FLG
NYSE:FLGBanks

Flagstar Bank (FLG) Stock Tests Narratives As H1 Return To Profit Meets Credit Concerns

Flagstar Bank National Association (FLG) opened 2026 with first half revenue of US$996 million and basic EPS of US$0.09, while trailing twelve month revenue came in at about US$2.0 billion and EPS of US$0.04. The company has seen revenue move from US$1.70 billion to US$1.88 billion and then to US$2.03 billion on a trailing basis, with EPS shifting from a loss of US$1.66 to a loss of US$0.51 before reaching a modest profit. For investors, the latest print points to margins that have stabilised...
NYSE:DOUG
NYSE:DOUGReal Estate

Douglas Elliman Stock And Manhattan Real Estate Plays Riding Luxury Redevelopment

The Flatiron Building’s conversion into ultra luxury condos, with units reportedly priced as high as US$58.5 million, has thrown a spotlight on Manhattan’s high end property market and the businesses tied to it. With tourists returning, the scaffolding removed, and renewed interest in the surrounding district, investors are asking which stocks are most exposed to this wave of redevelopment and rising visibility. This article breaks down 3 stocks from the Manhattan Luxury Real Estate...
NasdaqGS:MCRI
NasdaqGS:MCRIHospitality

Monarch Casino & Resort (MCRI) Stock Looks Reasonable On Cash Flow While Earnings Look Stretched

Monarch Casino & Resort has more than doubled investors' money over the past five years, yet there is a clear split between valuation tools, with a Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market multiples lean the other way. Over five years, Monarch Casino & Resort has returned 109.9%, which puts extra focus on whether recent gains are still backed by fundamentals. Recent record results and the company’s ongoing interest in acquisitions can support...